ProCE Banner Activity

Representation of Women, Black People and People of Color, and Older Adults in Studies Evaluating Long-Acting Antiretroviral Therapy

Conference Coverage
Slideset

In implementation and real-world studies of long-acting cabotegravir and rilpivirine, participant populations did not reflect local or global proportions of females living with HIV.

Released: October 25, 2023

Share

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc., Janssen Therapeutics, Division of Janssen Products, LP., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Janssen Therapeutics, Division of Janssen Products, LP

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare